Citizens Downgrades Sionna Therapeutics (SION) to Market Perform
Citizens analyst Jonathan Wolleben downgraded Sionna Therapeutics (NASDAQ: SION) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
